Updated just now · Live
Stock analysis, price data, and AI-powered insights for Charles River Laboratories (CRL).
Charles River Laboratories operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for CRL.
How to read insider trading filings
Johnson & Johnson
UnitedHealth Group Incorporated
AbbVie Inc.
Merck & Co., Inc.
Eli Lilly and Company
Thermo Fisher Scientific Inc.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). CRL Stock Intelligence Report. [stoxpulse.com/stocks/crl]
Disclaimer: The information on this page about Charles River Laboratories (CRL) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Charles River Laboratories.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No earnings data available.
Charles River Launches Rat In Vitro Fertility Serv...
2h ago
Middle East and Africa Cell and Gene Therapy Manuf...
22h ago
StoxPulse AI results for CRL: Pulse Score 40.5/100. Primary sentiment trends from 4 news sources and 20 SEC filings indicate a neutral outlook.
Market Cap
$8.08B
P/E Ratio
—
EPS
$1.10
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Sector
Healthcare
Industry
Life Sciences Tools & Services
Charles River Launches Rat In Vitro Fertility Services Demonstrating Embryology Capabilities
Middle East and Africa Cell and Gene Therapy Manufacturing Market Report 2026 Featuring Catalent, Charles River Labs, Lonza, Merck, Thermo Fisher Scientific, and WuXi AppTec
Here's Why Charles River Laboratories (CRL) is a Strong Value Stock
1 S&P 500 Stock to Own for Decades and 2 We Find Risky